Ahammune Biosciences Pvt. Ltd. Revenue and Competitors
Estimated Revenue & Valuation
- Ahammune Biosciences Pvt. Ltd.'s estimated annual revenue is currently $2M per year.
- Ahammune Biosciences Pvt. Ltd.'s estimated revenue per employee is $155,000
Employee Data
- Ahammune Biosciences Pvt. Ltd. has 13 Employees.
- Ahammune Biosciences Pvt. Ltd. grew their employee count by 8% last year.
Ahammune Biosciences Pvt. Ltd.'s People
Name | Title | Email/Phone |
---|---|---|
1 | Co-founder and CEO | Reveal Email/Phone |
Ahammune Biosciences Pvt. Ltd. Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $27.7M | 179 | 46% | N/A | N/A |
#2 | $92.2M | 595 | 72% | N/A | N/A |
#3 | $90.4M | 583 | 30% | N/A | N/A |
#4 | $2M | 13 | 8% | N/A | N/A |
#5 | $2.6M | 17 | 13% | N/A | N/A |
#6 | $1.4M | 9 | 80% | N/A | N/A |
#7 | $18.6M | 120 | 90% | $16.6M | N/A |
#8 | $3.7M | 24 | 14% | N/A | N/A |
What Is Ahammune Biosciences Pvt. Ltd.?
Ahammune Biosciences Pvt. Ltd. is a startup company based in Pune. Ahammune Biosciences is an innovation-led drug discovery company started in 2016 which focuses on developing new treatment options for immune mediated diseases of the skin. Our current program is on the depigmenting disorder, Vitiligo.\nThe current treatments for Vitiligo provide only temporary and symptomatic relief. Thus, there is an enormous unmet global need in treating patients with Vitiligo. The mission of Ahammune Biosciences is to arrest the progress of Vitiligo and to induce re-pigmentation of depigmented patches.\nWe are committed to take our innovation-driven drug discovery platform to the next level to demonstrate to the world that we as a nation can foster new molecules for complex diseases.
keywords:N/AN/A
Total Funding
13
Number of Employees
$2M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.1M | 13 | 117% | N/A |
#2 | $1.4M | 13 | -13% | N/A |
#3 | $2M | 13 | 0% | N/A |
#4 | $2M | 13 | -48% | N/A |
#5 | N/A | 13 | -7% | N/A |